跳至主要内容
临床试验/NCT05130125
NCT05130125已完成不适用

Retrospective Cohort Observational Study to Evaluate the Effectiveness and Safety of Fresh or Frozen Embryo Transfer After Ovarian Hyperstimulation (Administration of rFSH or HP-hMG Alone or Co-administration of rFSH and HP-hMG)

LG Chem1 个研究点 分布在 1 个国家目标入组 1,166 人开始时间: 2021年9月14日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,166
试验地点
1
主要终点
Number of Oocytes

研究概览

简要总结

A multicenter, retrospective cohort observational study to evaluate the effectiveness and safety of fresh or frozen embryo transfer after ovarian hyperstimulation (administration of rFSH or HP-hMG alone or co-administration of rFSH and HP-hMG)

详细描述

A multicenter, retrospective cohort observational study to evaluate the effectiveness and safety of fresh or frozen embryo transfer after ovarian hyperstimulation (administration of rFSH or HP-hMG alone or co-administration of rFSH and HP-hMG) to infertile female patients undergoing assisted reproductive technology to controlled ovarian hyperstimulation

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
19 Years 至 39 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • First IVF-ET cycle patients

排除标准

  • Poor ovarian responder
  • At least two of the following three features must be present: (i) Advanced maternal age (≥ 40 years) or any other risk factor for Poor ovarian response (POR); (ii) A previous POR (≤ 3 oocytes with a conventional stimulation protocol); (iii) An abnormal ovarian reserve test (i.e. AFC < 5-7 follicles or AMH < 0.5-1.1 ng/mL)

研究组 & 干预措施

fresh embryo

fresh embryo transfer after ovarian hyperstimulation

干预措施: rFSH (Drug)

frozen embryo

frozen embryo transfer after ovarian hyperstimulation

干预措施: rFSH (Drug)

结局指标

主要结局

Number of Oocytes

时间窗: average of 14 days

Counting number of Oocytes

次要结局

未报告次要终点

研究者

发起方
LG Chem
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Retrospective Cohort Observational Study to Evaluate... | 临床试验